Interplay between methylenetetrahydrofolate reductase gene polymorphism 677C→T and serum folate levels in determining hyperhomocysteinemia in heart transplant recipients

Journal of Heart and Lung Transplantation

Volumn 20, Issue 12, 2001, Pages 1245-1251

  Potena, Luciano ^a   Grigioni, Francesco ^a   Viggiani, Mariagabriella ^b   Magnani, Gaia ^a   Sorbello, Simona ^a   Falchetti, Elena ^a   Sassi, Simonetta ^c   Mantovani, Vilma ^b   Bacchi Reggiani, Letizia ^a   Magelli, Carlo ^a,c   Branzi, Angelo ^a  

^a Department of Clinical and Experimental Medicine   (Italy)

^b Laboratory of Cell Biology   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYCLOSPORIN; DRUG METABOLITE; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DNA POLYMORPHISM; DRUG BLOOD LEVEL; FEMALE; FOLIC ACID BLOOD LEVEL; GENETIC PREDISPOSITION; GENOTYPE; HEART TRANSPLANTATION; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLISM; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL;

ADULT; AGED; CORONARY ARTERIOSCLEROSIS; FEMALE; FOLIC ACID; GENOTYPE; HEART TRANSPLANTATION; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY FUNCTION TESTS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS;

EID: 0035668627     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(01)00350-3     Document Type: Article

References (33)

1. The registry of the international society for heart and lung transplantation: Fourteenth official report
2. The spectrum of coronary artery pathologic findings in human cardiac allografts
3. Pathology and etiology of chronic rejection of the heart
4. Cardiac allograft vasculopathy: A review
5. Hyperhomocyst(e)inaemia: A common and easily reversible risk factor for occlusive atherosclerosis
6. Homocysteine and coronary atherosclerosis
7. Homocysteine, diet and cardiovascular disease
8. Association of mild hyperhomocysteinemia with cardiac graft vascular disease
9. High homocysteinemia, low folate and low vitamin B6 concentration: Prevalent risk factors for vascular disease in heart transplant recipients
10. Cardiac allograft vascular disease after orthotopic heart transplantation: Methylenetetrahydrofolate reductase gene polymorphism C677T does not account for rapidly progressive forms
11. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase
12. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
13. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
14. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine and folate in subjects from Northern Italy with or without angiographically doumented severe coronary atherosclerotic disease: Evidence for an important genetic-environmental interaction
15. Serum total homocysteine concentration in the third national health and nutrition examination survey (1991-94): Population reference ranges and contribution of vitamin status to high serum concentration
16. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease
17. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease
18. Prospective study of coronary artery disease incidence in relation to fasting total homocysteinemia, related genetic polymorphisms, and B vitamins
19. Methylenetetrahydrofolate reductase gene and coronary artery disease
20. The methylenetetrahydrofolate reductase gene is associated with increased cardiovascular risk in Japan, but not in other populations
21. Prevalence of methylenetetrahydrofolate reductase C677T and its association with arterial and venous thrombosis in the Chinese population
22. Hyperhomocysteinemia in heart transplanted recipients
23. Increasing plasma homocysteine during follow-up in heart transplant recipients: Effect of folate and renal function
24. Worldwide distribution of a common methylenetetrahydrofolate reductase mutation
25. Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection
26. Plasma homocysteine level in a cohort of apparently healthy subjects in Northern Italy. Relation to age, sex, and nutritional status
27. Effect of immunosuppressive therapy, serum creatinine and time after transplant on plasma homocysteine in patients following heart transplantation
28. Increase in total plasma homocysteine concentration after cardiac transplantation
29. Correlation between total homocysteine and cyclosporine concentrations in cardiac transplant recipients
30. Hyperhomocysteinemia in cyclosporine treated renal transplant recipients
31. Pathophysiology of Cyclosporin A nephrotoxocity: Experimental and clinical observations
32. Effect of Sandimmune cyclosporine on renal blood flow and renal function in heart transplant recipients
33. High frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy